SCHEMBL779608

SCHEMBL779608

c1cc(C2CCCCC2)c(C2CCCCC2)cc1C1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.47
ACMSD Q8TDX5 2/20 0.46
BACE1 P56817 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
EPHX2 P34913 1/20 0.43
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
HSP90AA1 P07900 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
CEL P19835 2/20 0.40
CYP11B2 P19099 1/20 0.39
HTR1D P28221 1/20 0.38
PDK2 Q15119 1/20 0.38
HTT P42858 2/20 0.38
CYP2D6 P10635 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL778496 0.98 HDAC8 (0.46) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL28024270 0.87 ACMSD (0.43) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL5289225 0.81 BACE1 (0.49) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL3786167 0.81 SLC6A2 (0.50) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL3361525 0.81 ACMSD (0.54) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL4958890 0.81 ACMSD (0.54) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL2091525 0.81 ACMSD (0.46) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL3787199 0.81 SLC6A2 (0.50) KMOACMSDBACE1EPHX2KMT2A
SCHEMBL4960985 0.81 ACMSD (0.54) KMOACMSDBACE1HDAC4HDAC2
SCHEMBL11277728 0.81 ACMSD (0.42) KMOACMSDBACE1EPHX2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20220149436-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2022-05-12 US disclosed
US-11283107-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2022-03-22 US disclosed
US-10941099-B2 Cyclohexanone-containing products and processes for making the same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-03-09 US disclosed
US-10752570-B2 Processes for making cyclohexanone EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-08-25 US disclosed
US-10745336-B2 Cyclohexanone-containing products and processes for making the same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-08-18 US disclosed
US-20200190006-A1 Processes for Making Cyclohexanone EXXONMOBIL CHEMICAL PATENTS INC (US) 2020-06-18 US disclosed
US-20200123088-A1 Cyclohexanone-Containing Products and Processes for Making the Same EXXONMOBIL CHEMICAL PATENTS INC. 2020-04-23 US disclosed
US-20200123089-A1 Cyclohexanone-Containing Products and Processes for Making the Same EXXONMOBIL CHEMICAL PATENTS INC (US) 2020-04-23 US disclosed
EP-3621141-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2020-03-11 EP disclosed
WO-2014043188-A1 PROCESS FOR PRODUCING PHENOL AND/OR CYCLOHEXANONE FROM CYCLOHEXYLBENZENE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-03-20 WO disclosed
WO-2014028139-A1 PROCESS FOR PRODUCING CYCLOHEXYLBENZENE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-02-20 WO disclosed
CN-103259044-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery MITSUBISHI CHEM CORP 2013-08-21 CN disclosed
US-20120177988-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-07-12 US disclosed
CN-101432923-B Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery MITSUBISHI CHEM CORP 2012-04-18 CN disclosed
US-20120070731-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-03-22 US disclosed
CN-102097654-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery MITSUBISHI CHEM CORP 2011-06-15 CN disclosed
US-20090325065-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2009-12-31 US disclosed
CN-101432923-A Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery MITSUBISHI CHEM CORP (JP) 2009-05-13 CN disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200123089-A1 Cyclohexanone-Containing Products and Processes for Making the Same CTRC, DCXR, BCKDK KMO 187/4885ACMSD 95/4885BACE1 2905/4885
US-10941099-B2 Cyclohexanone-containing products and processes for making the same HYPK, BCKDK, KHK KMO 85/4885ACMSD 61/4885BACE1 1405/4885
US-10745336-B2 Cyclohexanone-containing products and processes for making the same CTRC, DCXR, BCKDK KMO 187/4885ACMSD 95/4885BACE1 2905/4885
US-20200190006-A1 Processes for Making Cyclohexanone HPD, GCK, BCKDK KMO 166/4885ACMSD 199/4885BACE1 2886/4885
US-20200123088-A1 Cyclohexanone-Containing Products and Processes for Making the Same HYPK, BCKDK, KHK KMO 85/4885ACMSD 61/4885BACE1 1405/4885
US-10752570-B2 Processes for making cyclohexanone HPD, GCK, KHK KMO 222/4885ACMSD 100/4885BACE1 1951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.